Hyperthermia and Reirradiation

Part of the Medical Radiology book series (MEDRAD)


Quality-assured local and regional hyperthermia procedures have been proven to enhance the clinical benefits of oncological standard treatments in several clinical settings without a substantial increase of late toxicity. This makes hyperthermia an attractive sensitizer for both, radiotherapy and chemotherapy. It is no longer the question whether hyperthermia is an effective oncological treatment at all. Currently, the question is which patient, which tumor entity, and which clinical stage of disease benefits most from additional hyperthermia as integral part of current multi-modality oncological treatment schedules. This remains particularly true for patients with recurrent malignant diseases and a previous irradiation series in the involved area.


Rectal Cancer Recurrent Rectal Cancer Hyperthermia Treatment Chest Wall Recurrence Regional Hyperthermia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Computed tomography


Magnetic resonance imaging


Superficial hyperthermia


Interstitial hyperthermia


Deep regional hyperthermia


Whole body hyperthermia


Hyperthermic intraoperative peritoneal chemotherapy






Primary locally advanced


Locally recurrent




  1. Berdov BA, Menteshashvili GZ (1990) Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 6:881–890PubMedCrossRefGoogle Scholar
  2. Colombo R, Da Pozzo LF, Salonia A et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270–4276PubMedCrossRefGoogle Scholar
  3. Cornett WR, McCall LM, Petersen RP et al (2006) Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 24:4196–4201PubMedCrossRefGoogle Scholar
  4. Datta NR, Bose AK, Kapoor HK, Gupta S (1990) Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 6:479–486PubMedCrossRefGoogle Scholar
  5. De Haas-Kock DF, Buijsen J, Pijls-Johannesma M et al (2009) Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev CD006269Google Scholar
  6. Dresen RC, Gosens MJ, Martijn H et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947PubMedCrossRefGoogle Scholar
  7. Franckena M, De Wit R, Ansink AC et al (2007) Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. Int J Hyperthermia 23:443–450PubMedCrossRefGoogle Scholar
  8. Franckena M, Stalpers LJ, Koper PC et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176–1182PubMedCrossRefGoogle Scholar
  9. Franckena M, Lutgens LC, Koper PC et al (2009) Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients. Int J Radiat Oncol Biol Phys 73:242–250PubMedCrossRefGoogle Scholar
  10. Geiger M, Strnad V, Lotter M, Sauer R (2002) Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer. Brachytherapy 1:149–153PubMedCrossRefGoogle Scholar
  11. Gellermann J, Wlodarczyk W, Hildebrandt B et al (2005) Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res 65:5872–5880PubMedCrossRefGoogle Scholar
  12. Gellermann J, Hildebrandt B, Issels R et al (2006) Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 107:1373–1382PubMedCrossRefGoogle Scholar
  13. Hildebrandt B, Wust P, Drager J et al (2004) Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. Int J Hyperthermia 20:359–369PubMedCrossRefGoogle Scholar
  14. Hildebrandt B, Hegewisch-Becker S, Kerner T et al (2005) Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’. Int J Hyperthermia 21:169–183PubMedCrossRefGoogle Scholar
  15. Issels RD, Lindner LH, Verweij J et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–570PubMedCrossRefGoogle Scholar
  16. Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085PubMedCrossRefGoogle Scholar
  17. Juffermans JH, Hanssens PE, van Putten WL et al (2003) Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer 98:1759–1766PubMedCrossRefGoogle Scholar
  18. Kouloulias V, Plataniotis G, Kouvaris J et al (2005) Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. Am J Clin Oncol 28:91–99PubMedCrossRefGoogle Scholar
  19. Milani V, Pazos M, Issels RD et al (2008) Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Strahlenther Onkol 184:163–168PubMedCrossRefGoogle Scholar
  20. Mochiki E, Shioya M, Sakurai H et al (2007) Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding. Int J Hyperthermia 23:493–500PubMedCrossRefGoogle Scholar
  21. Ott OJ, Rödel C, Weiss C et al (2009) Radiochemotherapy for Bladder Cancer. Clin Oncol (R Coll Radiol) 21:557–565CrossRefGoogle Scholar
  22. Overgaard J, Gonzalez Gonzalez D, Hulshof MC et al (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 345:540–543PubMedCrossRefGoogle Scholar
  23. Rau B, Benhidjeb T, Wust P, Schlag PM (2002) Stellenwert der Hyperthermie für die chirurgische Onkologie (German). Viszeralchirurgie 37:379–384CrossRefGoogle Scholar
  24. Rietbroek RC, Schilthuis MS, Bakker PJ et al (1997) Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79:935–943PubMedCrossRefGoogle Scholar
  25. Schaffer M, Krych M, Pachmann S et al (2003) Feasibility and morbidity of combined hyperthermia and radiochemotherapy in recurrent rectal cancer—preliminary results. Onkologie 26:120–124PubMedCrossRefGoogle Scholar
  26. Schlemmer M, Lindner LH, Abdel-Rahman S, Issels RD (2004) Principles, technology and indication of hyperthermia and part body hyperthermia. Radiologe 44:301–309PubMedCrossRefGoogle Scholar
  27. Sneed PK, Stauffer PR, McDermott MW et al (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:287–295PubMedCrossRefGoogle Scholar
  28. Tilly W, Gellermann J, Graf R et al (2005) Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol 181:35–41PubMedCrossRefGoogle Scholar
  29. Valdagni R, Amichetti M (1994) Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163–169PubMedCrossRefGoogle Scholar
  30. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC et al (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–1125PubMedCrossRefGoogle Scholar
  31. Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731–744PubMedCrossRefGoogle Scholar
  32. Verwaal VJ, Bruin S, Boot H et al (2008) 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–2432PubMedCrossRefGoogle Scholar
  33. Wiig JN, Larsen SG, Dueland S, Giercksky KE (2005) Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 92:70–75PubMedCrossRefGoogle Scholar
  34. Wittlinger M, Rodel CM, Weiss C et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358–363PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity Hospital ErlangenErlangenGermany

Personalised recommendations